Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 21, Pages 5306
Publisher
MDPI AG
Online
2023-11-07
DOI
10.3390/cancers15215306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet
- (2023) Suresh R. Giri et al. BMC CANCER
- Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
- (2023) Xing Ying et al. Frontiers in Microbiology
- Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
- (2023) Neda Yahoo et al. JOURNAL OF HEPATOLOGY
- Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease
- (2023) Jannis Kountouras et al. CLINICAL IMMUNOLOGY
- Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
- (2023) Vanda Marques et al. CLINICAL SCIENCE
- Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
- (2023) Stergios A. Polyzos et al. SEMINARS IN CANCER BIOLOGY
- The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
- (2023) Ilias D. Vachliotis et al. Current Obesity Reports
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
- (2022) Pierluigi Ramadori et al. HEPATOLOGY
- TNF in the liver: targeting a central player in inflammation
- (2022) Gisa Tiegs et al. Seminars in Immunopathology
- Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
- (2022) Lampros Chrysavgis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD
- (2022) Simon Wabitsch et al. JOURNAL OF HEPATOLOGY
- Adiponectin and the risk of gastrointestinal cancers in East Asians: Mendelian randomization analysis
- (2022) Hua Jiang et al. Cancer Medicine
- Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
- (2022) Yamei Duan et al. Frontiers in Immunology
- Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
- (2022) Muchun Li et al. Frontiers in Oncology
- Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
- (2022) Stergios A. Polyzos et al. Current Obesity Reports
- Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
- (2022) Linda Henry et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
- (2022) Eslam E. Abd El-Fattah et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
- (2022) Meenakshi Vachher et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Combination Therapies for Nonalcoholic Fatty Liver Disease
- (2022) Evangelia S. Makri et al. Journal of Personalized Medicine
- NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
- (2022) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy
- (2022) Amaia Lujambio et al. JOURNAL OF HEPATOLOGY
- Liraglutide enhances the effect of checkpoint blockade through the inhibition of neutrophil extracellular traps in murine lung and liver cancers
- (2022) Duo Chen et al. FEBS Open Bio
- The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
- (2022) Qing Tang et al. Frontiers in Immunology
- Metformin in patients with hepatocellular carcinoma receiving immunotherapy
- (2022) Huapeng Lin et al. JOURNAL OF HEPATOLOGY
- Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
- (2022) Apriliana E. R. Kartikasari et al. Frontiers in Immunology
- Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace
- (2022) Krizia Pocino et al. Journal of Personalized Medicine
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
- (2021) Kanokwan Pinyopornpanish et al. Gut and Liver
- Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC
- (2021) Yueqi Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
- (2021) Gian Paolo Caviglia et al. Cancers
- Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
- (2021) Luca Valenti et al. DIGESTIVE AND LIVER DISEASE
- Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease
- (2021) Evangelia S. Makri et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
- (2021) Judith Dalem et al. HEPATOLOGY
- Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
- (2021) Victoria Potoupni et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
- (2021) Sijia Lu et al. Journal of Genetics and Genomics
- Impact of Incretin-Based Therapies on Adipokines and Adiponectin
- (2021) Habib Yaribeygi et al. Journal of Diabetes Research
- Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
- (2021) Rasoul Akbari et al. BMC Pharmacology & Toxicology
- Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
- (2021) Ziniu Ding et al. Frontiers in Immunology
- The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
- (2021) Noe Rico Montanari et al. Cancers
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
- (2020) Zhi Li et al. Cancer Cell International
- Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
- (2020) Won Jin Ho et al. Journal for ImmunoTherapy of Cancer
- Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
- (2020) Seo-Young Koo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
- (2020) Motoyasu Kojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
- (2020) Evangelia Makri et al. ARCHIVES OF MEDICAL RESEARCH
- The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis
- (2020) Lilong Zhang et al. BMC CANCER
- Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis
- (2020) Citrawati Dyah Kencono Wungu et al. BMC CANCER
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Hepatokines and adipokines in NASH-related hepatocellular carcinoma
- (2020) Ozlem Kucukoglu et al. JOURNAL OF HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
- (2019) Yoon Yang et al. SEMINARS IN LIVER DISEASE
- Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block
- (2019) Vasilios G. Athyros et al. Current Vascular Pharmacology
- TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells
- (2019) Yongxu Chen et al. EXPERIMENTAL CELL RESEARCH
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma
- (2019) Haoran Li et al. Translational Cancer Research
- Insights into the success and failure of systemic therapy for hepatocellular carcinoma
- (2019) Jordi Bruix et al. Nature Reviews Gastroenterology & Hepatology
- The TNF Paradox in Cancer Progression and Immunotherapy
- (2019) Anne Montfort et al. Frontiers in Immunology
- Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats
- (2019) Entsar A. Nazmy et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
- (2019) Teruo Jojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells
- (2018) Yingying Jing et al. CANCER LETTERS
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC
- (2018) Divya P. Kumar et al. HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obesity and cancer risk: Emerging biological mechanisms and perspectives
- (2018) Konstantinos I. Avgerinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
- (2018) Wenliang Tan et al. EBioMedicine
- Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
- (2017) Andrea Casadei Gardini et al. EUROPEAN JOURNAL OF CANCER
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis
- (2017) M Zhou et al. ONCOGENE
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma
- (2016) Mohammed M.H. Al-Gayyar et al. BIOLOGICAL CHEMISTRY
- Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes
- (2016) J.-R. Su et al. HORMONE AND METABOLIC RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies
- (2016) Tai Wei et al. Oncotarget
- Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma
- (2016) Hongmei Wang et al. MEDICAL SCIENCE MONITOR
- Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients
- (2014) Abby B. Siegel et al. ONCOLOGY
- Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma
- (2014) Eun Shin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Obesity, adipokines and hepatocellular carcinoma
- (2013) Xiao-Feng Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Increased adiponectin associated with poor survival in hepatocellular carcinoma
- (2013) Shen-Nien Wang et al. JOURNAL OF GASTROENTEROLOGY
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Editorial [Hot Topic Adiponectin in Health and Disease: Current Evidence and Therapeutic Perspectives (Guest Editor: Stergios A. Polyzos)]
- (2012) Stergios A. Polyzos CURRENT MEDICINAL CHEMISTRY
- TNF-Dependent Signaling Pathways in Liver Cancer: Promising Targets for Therapeutic Strategies?
- (2012) Christoph Roderburg et al. DIGESTIVE DISEASES
- Adipocytokines and Hepatocellular Carcinoma
- (2012) Verena Wieser et al. DIGESTIVE DISEASES
- The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients
- (2012) N A H Sadik et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Nonalcoholic Fatty Liver Disease
- (2012) Stergios A. Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- TNF signaling drives myeloid-derived suppressor cell accumulation
- (2012) Xueqiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
- Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas
- (2011) S. A. Polyzos et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors
- (2010) John T. Heiker et al. BIOLOGICAL CHEMISTRY
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
- (2010) P. Matafome et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
- (2010) Neeraj K. Saxena et al. GASTROENTEROLOGY
- Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis
- (2010) HEPATOLOGY RESEARCH
- Nonlinear Distribution of Adiponectin in Patients With Nonalcoholic Fatty Liver Disease Limits Its Use in Linear Regression Analysis
- (2010) Stergios Alexandros Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin
- (2010) Stergios A. Polyzos et al. MEDICAL HYPOTHESES
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
- (2009) Stergios Polyzos et al. CURRENT MOLECULAR MEDICINE
- The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
- (2009) Stergios A. Polyzos et al. DIABETES OBESITY & METABOLISM
- Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
- (2009) Takeharu Asano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search